Notably, GSCs not only exhibit intrinsic resistance to TMZ due to the high expression of the ABCB4 efflux pump, particularly evident in CD133-positive GSCs, but also contribute to the development of a broader tumor resistance. The gene discussed is ABCB4; the disease is neoplasm.